|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Genocea Biosciences, Inc. (GNCA) |
|
|
$0.59 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
39 |
|
|
|
Total
Direct Shares :
|
2,507,114 |
|
|
Total
Indirect Shares :
|
40,736,815 |
| |
%
Held by Insiders:
|
4.85% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Duvall Diantha |
CHIEF FINANCIAL OFFICER |
2022-06-02 |
75,388 |
2020-04-02 |
0 |
| Flechtner Jessica Baker |
Chief Scientific Officer |
2022-06-02 |
89,027 |
2014-09-11 |
0 |
| Clark William D |
President and CEO, Director |
2022-06-02 |
304,377 |
2014-09-02 |
0 |
| Sumer Jacquelyn L |
CHIEF LEGAL & COMPLIANCE OFF |
2022-06-01 |
43,000 |
|
0 |
| Siber George |
Director |
2022-05-27 |
252 |
|
0 |
| Stapleton Raymond D Jr |
CHIEF TECHNOLOGY OFFICER |
2022-05-25 |
43,750 |
2022-03-15 |
0 |
| Nea 16 Gp, Llc |
10% Owner |
2022-05-25 |
0 |
2019-02-14 |
0 |
| Davis Thomas Andrew |
CHIEF MEDICAL OFFICER |
2022-04-04 |
68,330 |
2020-04-02 |
0 |
| Aakalu Girish N |
CHIEF BUSINESS OFFICER |
2022-04-04 |
74,459 |
|
0 |
| Walker Paul Edward |
10% Owner |
2020-07-24 |
0 |
2022-05-25 |
0 |
| Singh Narinderjeet |
SENIOR VP, PS&M |
2020-06-01 |
8,365 |
2019-03-18 |
0 |
| Barris Peter J |
10% Owner |
2019-02-14 |
0 |
2019-06-24 |
7,225,676 |
| Behbahani Ali |
Director, 10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
| Baskett Forest |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
| Makower Joshua |
10% Owner |
2019-02-14 |
0 |
2020-07-24 |
10,376,936 |
| Sonsini Peter W. |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
| Makhzoumi Mohamad |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
| Chang Carmen |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
| Sandell Scott D |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
| Florence Anthony A. Jr. |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
| Mott David M |
10% Owner |
2019-02-14 |
0 |
2019-06-24 |
7,225,676 |
| Alfieri Michael |
Principle Financial Officer |
2018-09-13 |
10,000 |
2018-09-13 |
0 |
| Poole Jonathan |
Chief Financial Officer |
2017-07-24 |
39,247 |
2016-05-09 |
0 |
| Hetherington Seth V |
Chief Medical Officer |
2016-11-09 |
26,000 |
2014-08-18 |
0 |
| Hoffman Eric S |
Chief Business Officer |
2016-11-08 |
11,790 |
2016-11-07 |
0 |
| Giannasca Paul |
VP of Development |
2014-09-11 |
0 |
2014-08-27 |
0 |
| Polaris Venture Partners Special Founders Fund V, |
10% Owner |
2014-08-08 |
0 |
2015-06-19 |
1,968,606 |
| Hoffman Stephen J |
Director |
2014-02-10 |
0 |
2015-03-17 |
1,992,415 |
| Polaris Venture Partners V, L.p. |
10% Owner |
2014-02-10 |
0 |
2014-02-10 |
2,128,678 |
| Bitterman Kevin |
Director |
2014-02-10 |
0 |
2014-02-10 |
2,128,678 |
| Glaxosmithkline Plc |
10% Owner |
2014-02-10 |
0 |
2020-07-24 |
4,626,389 |
| George Simeon |
Director |
2014-02-10 |
0 |
2014-02-10 |
1,671,667 |
| Lux Ventures Ii, L.p. |
Former 10% Owner |
2014-02-10 |
1,682,037 |
|
0 |
| Johnson & Johnson Development Corp Et Al |
10% Owner |
2014-02-10 |
0 |
2014-03-12 |
1,392,094 |
| Bosley Katrine |
Director |
2014-02-04 |
31,092 |
|
0 |
| Meisner Derek M |
|
|
0 |
|
0 |
| Mayer Howard |
|
|
0 |
|
0 |
| Farrell Robert E Jr |
|
|
0 |
|
0 |
| Carroll Pamela |
|
|
0 |
|
0 |
|
|
